Discussion about this post

User's avatar
Neural Foundry's avatar

Really solid curation here. The Hims & Hers UK move is smart timing given how NHS wait times for specialist care keep pushing people toward private solutions. Telehealth companes scaling internationally always face the regulatory friction question tho, and I'm curious if they'll adapt their DTC model or partner locally. I've watched similar US healthtech players stumble on reimbursment dynamics abroad.

Expand full comment

No posts

Ready for more?